Background: HIV-1 is able to replicate in primary human macrophages without stimulating innate immune sensors despite reverse transcription of genomic RNA into double stranded DNA in the infected cell cytoplasm, an activity that might be expected to trigger innate pattern recognition receptors (PRRs). We hypothesized that if correctly orchestrated HIV-1 uncoating and nuclear entry is important for evasion of innate sensors, then manipulation of interactions with host factors that regulate these processes should trigger PRRs and stimulate type 1 interferon (IFN) secretion. For example, cofactors such as Cleavage and Polyadenylation Specificity Factor subunit 6 (CPSF6), Nup358, and Cyclophilin A have all been suggested to have a role in uncoating and/or nuclear entry. To test our hypothesis we used HIV-1 CA mutants N74D and P90A that are impaired in their interaction with CPSF6 or cyclophilins (Nup358 and CypA) respectively, leading to altered cofactor use at nuclear entry and retargeted integration preferences. To test the ability of these HIV-1 mutants to trigger innate sensors we infected human monocyte derived macrophages (MDM) with HIV-1 CA N74D or P90A and measured replication and production of soluble type-1 IFN. We found that HIV-1 encoding these CA mutations cannot replicate in MDM because it triggers cytoplasmic DNA sensors including cGAS, leading to nuclear translocation of NFκB and IRF3, the production of soluble type-1 IFN and induction of an antiviral state. Depletion of CPSF6 by shRNA expression in MDM allows wild type virus to trigger innate sensors and IFN production. In each case, suppressed replication is rescued by type 1 IFN-receptor (IFNAR2) blockade demonstrating a role for type 1 IFN in restriction. IFN production is dependent on viral reverse transcription consistent with viral DNA being the pathogen associated molecular pattern (PAMP). Finally, we show that we can pharmacologically induce wild type HIV-1 infection to stimulate IFN secretion and an antiviral state using a non-immunosuppressive cyclosporine analogue. Conclusions: We conclude that HIV-1 has evolved to utilize CPSF6 and cyclophilins to cloak its replication allowing evasion of innate immune sensors and induction of a cell autonomous innate immune response in primary human macrophages. We hypothesise that successful infection of MDM depends on correctly orchestrated reverse transcription at the nuclear pore with a largely intact CA structure in complex with nuclear pore components including Nup358. We propose that uncloaking HIV-1 with non-immunosuppressive cyclosporines will cause HIV-1 to trigger IFN production during transmission and act as a powerful prophylactic for HIV/AIDS and possibly an important antiviral therapy.